Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Indian Journal of Pathology & Microbiology|September 22, 2011
Assessment of HER2/Neu status by fluorescence in situ hybridization in immunohistochemistry-equivocal cases of invasive ductal carcinoma and aberrant signal patterns: a study at a tertiary cancer centerSudha S Murthy, D G Sandhya, Faiq Ahmed, et al.Acta Diabetologica|March 13, 2025
Understanding the link between insulin resistance and cognition: a cross-sectional study conducted in an urban, South Indian cohortAnjana J Menon, Monisha Selva, G Sandhya, et al.The Indian Journal of Medical Research|January 22, 2010
Cytogenetic evaluation of traffic policemen occupationally exposed to vehicular exhaustV Sree Devi, V Durga Rao, V V Hara Gopal, et al.Vaccine|March 20, 2021
Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label studySai Krishna Susarla, Sonali Palkar, Pardha Saradhi Sv, et al.Vaccine|September 2, 2023
Immunogenicity and safety of Mebella™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority studySai Krishna Susarla, Rahul Jahagirdar, Kheya Ghosh Uttam, et al.Vaccine|July 24, 2019
Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority studySai Krishna Susarla, Madhu Gupta, Mukta Mantan, et al.Vaccine|September 4, 2023
Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority studySai Krishna Susarla, Madhu Gupta, Kheya Ghosh Uttam, et al.Pageof 2